Centre for Addiction
and Mental Health

Technology Transfer

Industry Partnerships & Technology Transfer

Research Commercialization

CAMH’s Industry Partnerships and Technology Transfer Office has the following primary objectives:

1) To translate research discoveries by CAMH scientists into practical applications for the benefit of patients.
2) To raise awareness in industry of CAMH’s technologies and research expertise.
3) To promote an entrepreneurial culture at CAMH
4) To identify and protect CAMH’s inventions with commercial potential.

University of Toronto

The University's 12 affiliated teaching hospitals, including CAMH, are not subject to the university's intellectual property policies. They have their own policies and make their own arrangements with respect to relations with industry and the commercialization of intellectual property. The university and hospitals do, however, have an agreement with respect to joint inventions. Under this agreement, U of T and affiliated hospitals are obliged to mutually disclose such inventions to each other and then determine, on a case-by-case basis, which institution should take responsibility for a joint invention. Any revenues are shared under a negotiated formula, which takes into consideration the circumstances of each particular case.

In general if an invention was made on CAMH premises, then ownership of intellectual property vests with CAMH. If the invention was made in a facility located at the University of Toronto, then the invention is owned by the university and will be governed by the University Inventions Policy.

MaRS Innovation

MaRS Innovation (MI) is a non-profit organization with an independent industry-led Board of Directors, funded through the Government of Canada’s Networks of Centres of Excellence and contributions of its member institutions. MaRS Innovation provides an integrated commercialization platform that harnesses the economic potential of the exceptional discovery pipeline of 17 leading Toronto academic institutions. CAMH is one of those institutions that has entered into an agreement with MI to collaboratively commercialize certain novel technologies.

Share |